Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study.

Li-Ju ChenFei-Yuan HsiaoLi-Jiuan ShenFe-Lin Lin WuWoei TsayChien-Ching HungShu-Wen Lin

Published in: PloS one (2016)

Use of hypoprothrombinemia-inducing cephalosporins increases risk of hemorrhagic events. Close watch for hemorrhagic events is recommended when prescribing these cephalosporins, especially in patients who are at higher risk.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
primary care
chronic kidney disease
peritoneal dialysis
prognostic factors
cross sectional
emergency department
adverse drug